EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical characteristics of hospitalized children with mycoplasma pneumoniae pneumonia in Chinese tertiary hospitals during the 2023–2024 post-pandemic period

Xiancheng Wang, Xiaoshun Zheng, Longfei Wang, Lijuan Zhang, Yuming Xu, Shuang Deng, Lihao Li, Jie He

Frontiers in Cellular and Infection Microbiology · 2026

DOI: 10.3389/fcimb.2026.1652640 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Xiancheng Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Shenzhen Hospital of Southern Medical University, Shenzhen, China. Hauptthemen laut MEDLINE: Mycoplasma pneumoniae, Pneumonia, Mycoplasma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Backgrounds The COVID-19 pandemic and subsequent non-pharmaceutical interventions (NPIs) altered the epidemiological patterns of Mycoplasma pneumoniae (M. pneumoniae) infections. This study aimed to analyze the long-term trends of M. pneumoniae pneumonia (MPP) in children after NPI discontinuation, focusing on epidemiological, clinical and macrolide-resistant characteristics.

Methods

A retrospective analysis was conducted on 1342 hospitalized children with MPP from January 2023 to December 2024 in Shenzhen Hospital of Southern Medical University, China. MPP, macrolide-unresponsive MPP (MUMPP), and severe MPP (SMPP) were diagnosed according to predefined criteria. Differences between mutated MPP and MUMPP were investigated, and risk factors for MUMPP, SMPP and mixed infection were assessed.

Results

MPP exhibits a bimodal temporal distribution in 2023-2024, with the first peak occurring in November 2023, and the second smaller peak in August 2024. The macrolide resistance gene positive rate was 86.43% (121/140), but only 64.29% (90/140) were clinically unresponsive to macrolides ( P < 0.0001). Risk factors for MUMPP included older age, longer hospital stay, and severe cough. Approximately 25% of MPP cases progressed to SMPP, with younger age, prolonged cough, and higher inflammatory markers being associated with severity. Co-pathogen infections were common, and patients with mixed infections had distinct clinical and laboratory profiles compared to those with pure MPP.

Conclusions

This study highlights the complex epidemiological and clinical landscape of MPP in the post-pandemic era. The discordance between macrolide resistance genes and clinical treatment suggests that macrolides may still be effective in some cases. The identified risk factors and clinical features provide valuable insights for optimizing treatment strategies and managing pediatric MPP in the post-pandemic context.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycoplasma pneumoniaePneumonia, MycoplasmaChildChild, PreschoolFemaleHumansInfantMaleAnti-Bacterial AgentsChild, HospitalizedChinaCOVID-19Drug Resistance, BacterialHospitalizationMacrolidesRetrospective StudiesRisk FactorsTertiary Care Centers

Stichwörter der Autor:innen

M. pneumoniaeepidemiologylaboratory-clinical discordancemacrolide-resistancepneumoniapost-pandemic

Substanzen

Anti-Bacterial AgentsMacrolides

Autor:innen und Institutionen

  • Department of Pediatrics, Shenzhen Hospital of Southern Medical University, Shenzhen, China.
  • Department of Neurosurgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

Zitieren

APA

Wang, X., Zheng, X., Wang, L., Zhang, L., Xu, Y., Deng, S., Li, L., & He, J. (2026). Clinical characteristics of hospitalized children with mycoplasma pneumoniae pneumonia in Chinese tertiary hospitals during the 2023–2024 post-pandemic period. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1652640

Vancouver

Wang X, Zheng X, Wang L, Zhang L, Xu Y, Deng S, et al. Clinical characteristics of hospitalized children with mycoplasma pneumoniae pneumonia in Chinese tertiary hospitals during the 2023–2024 post-pandemic period. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2026.1652640

BibTeX
@article{Wang2026,
  author = {Wang, Xiancheng and Zheng, Xiaoshun and Wang, Longfei and Zhang, Lijuan and Xu, Yuming and Deng, Shuang and Li, Lihao and He, Jie},
  title = {Clinical characteristics of hospitalized children with mycoplasma pneumoniae pneumonia in Chinese tertiary hospitals during the 2023–2024 post-pandemic period},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  doi = {10.3389/fcimb.2026.1652640}
}
Kostenlos starten →